Skip to content
Important: This site presents data from the FDA Adverse Event Reporting System (FAERS). A report does not mean the drug caused the event. Full disclaimer.

DASATINIB vs EVEROLIMUS: Which Drug Is Safer?

Boost Your Natural Energy & Metabolism

Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.

Try Mitolyn Now

DASATINIB vs EVEROLIMUS: Safety Overview

Metric DASATINIB EVEROLIMUS
Total FAERS Reports 30,019 39,640
Deaths Reported 2,681 8,374
Death Rate 8.9% 21.1%
Hospitalizations 6,437 11,211
Average Patient Age 56.4 yrs 53.4 yrs
% Female Patients 51.9% 60.0%
FDA Approval Date Apr 22, 2025 Apr 12, 2018
Manufacturer Zydus Pharmaceuticals USA Inc. Amneal Pharmaceuticals NY LLC
Route ORAL ORAL
Marketing Status Prescription Prescription